Artificial Pancreas Device Systems Market Size Report, 2032

Artificial Pancreas Device Systems (APDS) Market - By Device Type (Threshold Suspend Device Systems, Control-to-range (CTR) Systems, Control-to-target (CTT) Systems), By End-use (Hospitals and Clinics, Homecare) – Global Forecast, 2023-2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; workings

1.3&nbsp;&nbsp;&nbsp; Forecast calculations

1.4&nbsp;&nbsp;&nbsp; Data Sources

1.4.1&nbsp;&nbsp;&nbsp; Primary

1.4.2&nbsp;&nbsp;&nbsp; Secondary

1.4.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.4.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Global artificial pancreas device systems market 360&deg; synopsis, 2018 &ndash; 2032

2.2&nbsp;&nbsp;&nbsp; Regional trends

2.3&nbsp;&nbsp;&nbsp; Device type trends

2.4&nbsp;&nbsp;&nbsp; End-use trends

Chapter 3&nbsp;&nbsp;&nbsp;Artificial Pancreas Device Systems Industry Insights

3.1&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.2&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.3&nbsp;&nbsp;&nbsp; Technology landscape

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Industry impact forces

3.5.1&nbsp;&nbsp;&nbsp; Growth drivers

3.5.1.1&nbsp;&nbsp;&nbsp;Growing prevalence of diabetes

3.5.1.2&nbsp;&nbsp;&nbsp;Rising demand for automated systems for glycemic control

3.5.1.3&nbsp;&nbsp;&nbsp;Technological advancements in continuous glucose monitoring sensors

3.5.1.4&nbsp;&nbsp;&nbsp;Increasing research and development activities by key players

3.5.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.5.2.1&nbsp;&nbsp;&nbsp;High cost of device systems and safety concerns

3.5.2.2&nbsp;&nbsp;&nbsp;Stringent regulatory framework

3.6&nbsp;&nbsp;&nbsp; Growth potential analysis

3.6.1&nbsp;&nbsp;&nbsp; By device type

3.6.2&nbsp;&nbsp;&nbsp; By end-use

3.7&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Competitive analysis of major market players, 2022

4.2.1&nbsp;&nbsp;&nbsp; Medtronic Plc

4.2.2&nbsp;&nbsp;&nbsp; Johnson &amp; Johnson Services Inc

4.2.3&nbsp;&nbsp;&nbsp; Tandem Diabetes Care, Inc.

4.3&nbsp;&nbsp;&nbsp; Competitive positioning matrix, 2022

4.4&nbsp;&nbsp;&nbsp; Strategic outlook matrix, 2022

Chapter 5&nbsp;&nbsp;&nbsp;Artificial Pancreas Device Systems Market Size and Forecast, By Device Type, 2018-2032 (USD Million &amp; Units)

5.1&nbsp;&nbsp;&nbsp; Key trends, by device type

5.2&nbsp;&nbsp;&nbsp; Threshold suspend device systems

5.3&nbsp;&nbsp;&nbsp; Control-to-range (CTR) systems

5.4&nbsp;&nbsp;&nbsp; Control-to-target (CTT) systems

Chapter 6&nbsp;&nbsp;&nbsp;Artificial Pancreas Device Systems Market Size and Forecast, By End-use, 2018-2032 (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by end-use

6.2&nbsp;&nbsp;&nbsp; Hospitals and clinics

6.3&nbsp;&nbsp;&nbsp; Homecare

6.4&nbsp;&nbsp;&nbsp; Others

Chapter 7&nbsp;&nbsp;&nbsp;Artificial Pancreas Device Systems Market Size and Forecast, By Region, 2018-2032 (USD Million &amp; Units)

7.1&nbsp;&nbsp;&nbsp; Key trends, by region

7.2&nbsp;&nbsp;&nbsp; North America

7.2.1&nbsp;&nbsp;&nbsp; U.S.

7.2.2&nbsp;&nbsp;&nbsp; Canada

7.3&nbsp;&nbsp;&nbsp; Europe

7.3.1&nbsp;&nbsp;&nbsp; Germany

7.3.2&nbsp;&nbsp;&nbsp; UK

7.3.3&nbsp;&nbsp;&nbsp; France

7.3.4&nbsp;&nbsp;&nbsp; Italy

7.3.5&nbsp;&nbsp;&nbsp; Spain

7.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

7.4&nbsp;&nbsp;&nbsp; Asia Pacific

7.4.1&nbsp;&nbsp;&nbsp; China

7.4.2&nbsp;&nbsp;&nbsp; Japan

7.4.3&nbsp;&nbsp;&nbsp; India

7.4.4&nbsp;&nbsp;&nbsp; Australia

7.4.5&nbsp;&nbsp;&nbsp; South Korea

7.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pcific

7.5&nbsp;&nbsp;&nbsp; Latin America

7.5.1&nbsp;&nbsp;&nbsp; Brazil

7.5.2&nbsp;&nbsp;&nbsp; Mexico

7.5.3&nbsp;&nbsp;&nbsp; Argentina

7.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

7.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

7.6.1&nbsp;&nbsp;&nbsp; Saudi Arabia

7.6.2&nbsp;&nbsp;&nbsp; South Africa

7.6.3&nbsp;&nbsp;&nbsp; UAE

7.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East &amp; Africa

Chapter 8&nbsp;&nbsp;&nbsp;Company Profiles

8.1&nbsp;&nbsp;&nbsp; Medtronic Plc

8.2&nbsp;&nbsp;&nbsp; Johnson &amp; Johnson Services Inc

8.3&nbsp;&nbsp;&nbsp; Bigfoot Biomedical

8.4&nbsp;&nbsp;&nbsp; Tandem Diabetes Care, Inc.

8.5&nbsp;&nbsp;&nbsp; Pancreum, Inc.

8.6&nbsp;&nbsp;&nbsp; TypeZero Technologies, LLC

8.7&nbsp;&nbsp;&nbsp; Beta Bionics

8.8&nbsp;&nbsp;&nbsp; Insulet Corporation

8.9&nbsp;&nbsp;&nbsp; Defymed

8.10&nbsp;&nbsp;&nbsp; Inreda Diabetic

8.11&nbsp;&nbsp;&nbsp; Diabeloop

Artificial Pancreas Device Systems APDS Market

Get a free sample of this report